CY1671A - A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride - Google Patents

A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride

Info

Publication number
CY1671A
CY1671A CY1671A CY167193A CY1671A CY 1671 A CY1671 A CY 1671A CY 1671 A CY1671 A CY 1671A CY 167193 A CY167193 A CY 167193A CY 1671 A CY1671 A CY 1671A
Authority
CY
Cyprus
Prior art keywords
phenylmethyl
dihydrochloride
piperazinyl
chlorophenyl
ethoxy
Prior art date
Application number
CY1671A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of CY1671A publication Critical patent/CY1671A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY1671A 1988-11-23 1993-05-14 A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride CY1671A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827391A GB8827391D0 (en) 1988-11-23 1988-11-23 Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride

Publications (1)

Publication Number Publication Date
CY1671A true CY1671A (en) 1993-05-14

Family

ID=10647347

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1671A CY1671A (en) 1988-11-23 1993-05-14 A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride

Country Status (16)

Country Link
KR (1) KR970009728B1 (fr)
AT (1) AT398971B (fr)
CA (1) CA1317300C (fr)
CY (1) CY1671A (fr)
DK (1) DK174543B1 (fr)
ES (1) ES2021907A6 (fr)
FI (1) FI91862C (fr)
GB (2) GB8827391D0 (fr)
GR (1) GR1000553B (fr)
HK (1) HK95892A (fr)
HU (1) HU205094B (fr)
NO (1) NO172342C (fr)
PH (1) PH25982A (fr)
PL (1) PL161379B1 (fr)
PT (1) PT92364B (fr)
SG (1) SG89492G (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10199031I2 (de) * 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
ATE177636T1 (de) * 1992-09-24 1999-04-15 Sepracor Inc Transdermale behandlung der nesselsucht mit optisch reinem (+)-cetirizin
AU703690B2 (en) * 1992-09-24 1999-04-01 Sepracor, Inc. Methods for treating allergic disorders using optically pure (+)cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
JP3476475B2 (ja) 1997-06-04 2003-12-10 株式会社アズウェル ピペラジンスルホンアミド誘導体およびその塩の製造方法
EP0919550A1 (fr) * 1997-11-26 1999-06-02 Ucb, S.A. Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
GR990100135A (el) * 1999-04-22 2000-12-29 Genepharm �.�. Μεθοδος παρασκευης του 2-(2-[4-[4-χλωροφαινυλο)(φαινυλο)μεθυλο]πιπεραζινο]αιθοξυ) οξικου οξεος και του διυδροχλωρικου αλατος αυτου
JP2002249487A (ja) * 2001-02-22 2002-09-06 Sumitomo Chem Co Ltd ４−（ｔｅｒｔ−ブトキシカルボニル）ピペラジン誘導体、その光学活性な酸付加塩、それらの製造法、およびそれらを用いる光学活性な１−［（置換フェニル）フェニルメチル］ピペラジンの製造法。
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
CN100378086C (zh) * 2003-01-23 2008-04-02 Ucb法奇姆股份有限公司 哌嗪衍生物和它们作为合成中间体的应用
KR100503443B1 (ko) 2004-02-02 2005-07-22 한림제약(주) 광학적으로 활성인 세티리진 또는 그의 염의 제조방법
AU2006222298B2 (en) * 2005-03-03 2011-02-24 Ucb Farchim Sa Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
HU227325B1 (en) * 2005-12-08 2011-03-28 Egis Gyogyszergyar Nyrt Process for the production of an intermediate of (dextro- and levo)- cetirizine
WO2008110586A2 (fr) 2007-03-12 2008-09-18 Krka, Tovarna Zdravil, D.D., Novo Mesto Nouveau procédé de préparation de la lévocétirizine et ses intermédiaires
SI22489A (sl) * 2007-03-12 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek za pripravo levocetirizina in njegovih intermediatov
EP2167479B1 (fr) 2007-06-15 2013-09-11 Symed Labs Limited Procédé de préparation d'énantiomères lévogyres et dextrogyres sensiblement optiquement purs de cétirizine à l'aide de nouveaux intermédiaires
WO2009062036A2 (fr) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
EP2062881B1 (fr) 2007-11-21 2011-02-23 Synthon B.V. Procédé pour la fabrication de N-(diphénylméthyl)pipérazines
NZ589492A (en) 2008-06-02 2012-06-29 Cipla Ltd Processes for the synthesis of levocetirizine and intermediates for use therein
EP2297122B1 (fr) * 2008-06-11 2014-05-21 KRKA, tovarna zdravil, d.d., Novo mesto Nouveau procédé pour la préparation de la lévocétirizine et de ses intermédiaires
KR100998067B1 (ko) 2008-09-08 2010-12-03 주식회사 삼오제약 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
US20110172425A1 (en) 2008-09-17 2011-07-14 Calyx Chemicals And Pharmaceuticals Pvt. Ltd. Novel water based process for the preparation of substituted diphenylmethyl piperazines
WO2010107404A1 (fr) 2009-03-16 2010-09-23 Mahmut Bilgic Combinaisons pharmaceutiques stables
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009398A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
WO2012101475A1 (fr) 2011-01-27 2012-08-02 Jubilant Life Sciences Limited Procédé de préparation amélioré d'antihistaminiques faisant appel à un nouvel intermédiaire carbamate
CN103044355A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的关键中间体及其制备方法
KR101418404B1 (ko) 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
KR102226833B1 (ko) 2013-06-28 2021-03-12 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성이 개선된 복합 과립 제형
CN104045607B (zh) * 2014-05-21 2016-04-13 丽珠医药集团股份有限公司 一种盐酸西替利嗪的纯化方法
CN105924409B (zh) * 2016-05-12 2019-01-08 浙江永宁药业股份有限公司 一种(r)-1-((2-氯苯基)-(苯基)-甲基)-哌嗪的拆分方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.

Also Published As

Publication number Publication date
GR890100770A (en) 1990-12-31
PH25982A (en) 1992-01-13
PT92364A (pt) 1990-05-31
KR900007825A (ko) 1990-06-02
ATA266589A (de) 1994-07-15
DK174543B1 (da) 2003-05-19
GB8827391D0 (en) 1988-12-29
GB2225321B (en) 1992-04-08
CA1317300C (fr) 1993-05-04
ES2021907A6 (es) 1991-11-16
NO172342B (no) 1993-03-29
AT398971B (de) 1995-02-27
DK586789A (da) 1990-05-24
HK95892A (en) 1992-12-11
NO894651D0 (no) 1989-11-22
GB8926243D0 (en) 1990-01-10
NO172342C (no) 1993-07-07
HU896131D0 (en) 1990-02-28
PL161379B1 (pl) 1993-06-30
NO894651L (no) 1990-05-25
KR970009728B1 (ko) 1997-06-17
PT92364B (pt) 1995-07-18
FI91862B (fi) 1994-05-13
GR1000553B (el) 1992-08-26
GB2225321A (en) 1990-05-30
HUT53627A (en) 1990-11-28
SG89492G (en) 1992-12-04
FI91862C (fi) 1994-08-25
FI895564A0 (fi) 1989-11-22
HU205094B (en) 1992-03-30
DK586789D0 (da) 1989-11-22

Similar Documents

Publication Publication Date Title
GB2225321B (en) A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride
GB2225320B (en) A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride
NO168771C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)dibenzo(b,f)-(1,4)-tiazepin og farmasoeytisk akseptable salter derav
HU9700744D0 (en) Process for the manufacture of 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]-ethoxy]-acetic acid and its salts
DK164364C (da) 4-(isoxazolyl)-thiazol-2-oxaminsyreforbindelser, en fremgangsmaade til fremstilling heraf, et mellemprodukt til brug ved fremgangsmaaden samt et farmaceutisk praeparat
PL287224A1 (en) Method of obtaining 2-(2-(4-(/4-chlorophenyl/phenylmethyl)-1-piperazinyl) ethoxy) acetic acid and its dihydrohloride
JPS57149282A (en) 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid and their derivatives as medicine
JPS6447776A (en) 1-(2-(phenylmethyl)phenyl)piperazine compound, manufacture and medicinal composition
EP0238905A3 (en) 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
GB2216417B (en) New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid
EP0041655A3 (en) 2-(2-amino-thiazol-4-yl)-n-(imidazolidin and perhydro-1,3-diazin-2-on-1-yl)-2-iminoacetylcephalosporins of the syn-form, and process for their preparation
ZA891858B (en) New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid
FI98728B (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi
CS224688A1 (en) 2-(biphenyl-4-yl)-5-phenyl-1,3,4-oxadiazole-4-carboxyl acid and its salts and method of their production
CS8904695A2 (en) Method of 2-(4-(2-(1-piperidinyl)-ethoxyl benzoyl) benzoic acid's 1-(4-amino-oxo-3,3-difenylbutyl)-1-methylpiperidinium bromide and methylester in liquid medicamentous forms determination